225 related articles for article (PubMed ID: 7598954)
1. Fate of intercellular MHC-peptide-T-cell receptor complexes during T-cell activation.
Clark BR
J Mol Recognit; 1995; 8(1-2):63-6. PubMed ID: 7598954
[TBL] [Abstract][Full Text] [Related]
2. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell.
Patel DM; Mannie MD
Cell Immunol; 2001 Dec; 214(2):165-72. PubMed ID: 12088415
[TBL] [Abstract][Full Text] [Related]
3. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
4. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
Dembic Z; Schenck K; Bogen B
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.
Harding CV; Unanue ER
Nature; 1990 Aug; 346(6284):574-6. PubMed ID: 2115981
[TBL] [Abstract][Full Text] [Related]
7. Thirty-six views of T-cell recognition.
Krummel M; Wülfing C; Sumen C; Davis MM
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1071-6. PubMed ID: 11186308
[TBL] [Abstract][Full Text] [Related]
8. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand.
Abraham C; Griffith J; Miller J
J Immunol; 1999 Apr; 162(8):4399-405. PubMed ID: 10201975
[TBL] [Abstract][Full Text] [Related]
9. T-T cellular interaction between CD4-CD8- regulatory T cells and T cell clones presenting TCR peptide. Its implication for TCR vaccination against experimental autoimmune encephalomyelitis.
Kozovska MF; Yamamura T; Tabira T
J Immunol; 1996 Aug; 157(4):1781-90. PubMed ID: 8759768
[TBL] [Abstract][Full Text] [Related]
10. Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC.
Zhao Y; Rodriguez-Barbosa JI; Zhao G; Shaffer J; Arn JS; Sykes M
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):217-28. PubMed ID: 11292257
[TBL] [Abstract][Full Text] [Related]
11. TCR, LFA-1, and CD28 play unique and complementary roles in signaling T cell cytoskeletal reorganization.
Sedwick CE; Morgan MM; Jusino L; Cannon JL; Miller J; Burkhardt JK
J Immunol; 1999 Feb; 162(3):1367-75. PubMed ID: 9973391
[TBL] [Abstract][Full Text] [Related]
12. TCR-mediated adhesion of T cell hybridomas to planar bilayers containing purified MHC class II/peptide complexes and receptor shedding during detachment.
Dustin ML; Miller JM; Ranganath S; Vignali DA; Viner NJ; Nelson CA; Unanue ER
J Immunol; 1996 Sep; 157(5):2014-21. PubMed ID: 8757322
[TBL] [Abstract][Full Text] [Related]
13. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
15. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling.
Dorfman JR; Stefanová I; Yasutomo K; Germain RN
Nat Immunol; 2000 Oct; 1(4):329-35. PubMed ID: 11017105
[TBL] [Abstract][Full Text] [Related]
17. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
18. [Molecular basis for detection of infectious agents].
Siegrist CA
Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
[TBL] [Abstract][Full Text] [Related]
19. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes.
Patel DM; Dudek RW; Mannie MD
Cell Immunol; 2001 Nov; 214(1):21-34. PubMed ID: 11902826
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: negative selection of immature thymocytes by a few peptide-MHC complexes: differential sensitivity of immature and mature T cells.
Peterson DA; DiPaolo RJ; Kanagawa O; Unanue ER
J Immunol; 1999 Mar; 162(6):3117-20. PubMed ID: 10092759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
